Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A two-timepoint framework for sensitive and specific single-cell activity screening.

Neuron·2026
Same author

Micronutrient status after Roux-en-Y gastric bypass in patients receiving intensive postoperative nutrition education: A retrospective cohort study.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same author

A consensus guide to preclinical indirect calorimetry experiments.

Nature metabolism·2025
Same author

Bone marrow neutrophil density regulates myelopoiesis during obesity and weight loss.

The Journal of experimental medicine·2025
Same author

Ethanol causes rapid decreases in the hepatic retinoid levels shaping the early steps of alcohol-associated liver disease.

Alcohol, clinical & experimental research·2025
Same author

Overfeeding induces adipose tissue release of distinct mitochondria.

Cell reports·2025

Related Experiment Video

Updated: Jul 9, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats.

Julia A Johnson1, Steven E Trasino, Anthony W Ferrante

  • 1Obesity Research Center, St. Luke's-Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, NY 10025, USA.

Obesity (Silver Spring, Md.)
|December 12, 2007
PubMed
Summary
This summary is machine-generated.

Thiazolidinediones (TZDs) reduce adipocyte size, and these effects persist even after stopping treatment and consuming a high-fat diet. However, metabolic improvements like lower insulin and triglycerides were not maintained.

More Related Videos

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice
04:46

Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice

Published on: February 3, 2023

Related Experiment Videos

Last Updated: Jul 9, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice
04:46

Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice

Published on: February 3, 2023

Area of Science:

  • Metabolic disease research
  • Adipose tissue biology
  • Pharmacology

Background:

  • Thiazolidinediones (TZDs) are anti-diabetic drugs known to promote adipocyte differentiation and reduce adipocyte size.
  • The long-term impact of TZD therapy on adipocyte morphology after treatment cessation, particularly under obesigenic conditions, remains understudied.

Purpose of the Study:

  • To investigate whether the reduced adipocyte size induced by thiazolidinediones (TZDs) is maintained after treatment discontinuation.
  • To assess the impact of an obesigenic diet on these TZD-induced changes in adipocyte morphology and metabolic markers.

Main Methods:

  • Adult female rats were fed either low-fat or high-fat diets and treated with rosiglitazone (ROSI) or a placebo for 6 weeks.
  • ROSI treatment was discontinued, and all rats were subsequently fed a high-fat diet for an additional 6 weeks.
  • Retroperitoneal adipose tissue morphology, body weight, adiposity, and circulating metabolic markers were analyzed.

Main Results:

  • Rosiglitazone (ROSI) treatment significantly decreased adipocyte size and increased DNA content in retroperitoneal adipose tissue, effects that persisted after treatment cessation.
  • Body weight and adiposity did not differ between groups after stopping ROSI, despite consumption of a high-fat diet.
  • While ROSI decreased insulin, leptin, and triglycerides and increased adiponectin during treatment, these metabolic improvements were reversed upon discontinuation.

Conclusions:

  • Thiazolidinedione (TZD)-induced reductions in adipocyte size and increases in cell number are maintained after treatment cessation, even when challenged with an obesigenic diet.
  • Further research is required to determine if sustained smaller adipocyte size comes at the cost of increased body weight in TZD-treated animals.